Similar articles

• The effect of pyridoxine-alpha-ketoglutarate (PAK) on exercise-induced increase of blood lactate in patients with type I diabetes.

  Dall'Aglio E, Zavaroni I, Alpi O, Coscelli C, Butturini U. Dall'Aglio E, et al. Int J Clin Pharmacol Ther Toxicol. 1982 Mar;20(3):147-50. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 7068289
• Metabolic effects of pyridoxine alpha-ketoglutarate in ophthalmoplegia plus.

  Scarlato G, Pellegrini G, Moggio M, Ferini Strambi L. Scarlato G, et al. Acta Neurol (Napoli). 1982 Apr;4(2):92-7. Acta Neurol (Napoli). 1982. PMID: 7113779 No abstract available.
• Effect of pyridoxine alpha-ketoglutarate (PAK) on ammonia and pyruvic and lactic acid blood levels in patients with cirrhosis.

  Salerno F, Abbiati R, Fici F. Salerno F, et al. Int J Clin Pharmacol Res. 1983;3(1):21-5. Int J Clin Pharmacol Res. 1983. PMID: 6679504
• [Red cell glycolytic intermediates].

  Fujii H. Fujii H. Nihon Rinsho. 1995 Mar;53 Su Pt 2:234-8. Nihon Rinsho. 1995. PMID: 8753225 Review. Japanese. No abstract available.
• [On the mechanism of action of biguanides in man].

  Beckmann R. Beckmann R. Arzneimittelforschung. 1969 Apr;19(4):628-33. Arzneimittelforschung. 1969. PMID: 4891526 Review. German. No abstract available.